Article Dans Une Revue ChemMedChem Année : 2025

Synthesis and 64Cu‐Radiolabeling Strategies of Small Organic Radioconjugates Based on the AMD070 Scaffold

Résumé

CXCR4 is a transmembrane receptor overexpressed in a large variety of cancer cells. In addition to classical antibody-and peptidetargeting for the development of positron emission tomography (PET) radiopharmaceuticals, this receptor possesses a range of small organic inhibitors that can be exploited. These are based mainly on nitrogen-rich scaffolds, such as AMD070, and cyclic polyamines, such as cyclam, in the AMD3100 skeleton. The latter has been explored as a direct 64 Cu chelator, but examples of CXCR4 PET imaging with small organic targeting units are still scarce in the literature. Herein, the synthesis of two novel CXCR4-directed radiopharmaceuticals is described, combining the AMD070 scaffold as a targeting unit and bifunctional te1pa macrocycle as a strong 64 Cu chelator. The synthesis of the conjugates and optimization of 64 Cu-radiolabeling are presented, opening the way for future in vitro and in vivo studies.

Domaines

Fichier principal
Vignette du fichier
21- ChemMedChem - 2025 - AMD070-te1pa-64Cu.pdf (1.12 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

hal-05113923 , version 1 (16-06-2025)

Licence

Identifiants

Citer

Marie M Le Roy, Patricia Le Saëc, Michel Chérel, Alain Faivre‐chauvet, Thibault Troadec, et al.. Synthesis and 64Cu‐Radiolabeling Strategies of Small Organic Radioconjugates Based on the AMD070 Scaffold. ChemMedChem, 2025, ⟨10.1002/cmdc.202500243⟩. ⟨hal-05113923⟩
77 Consultations
71 Téléchargements

Altmetric

Partager

  • More